{"organizations": [], "uuid": "0762aeaae4456f1dfd508de65dd6972e4ed0e1b0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180131.html", "section_title": "Archive News &amp; Video for Wednesday, 31 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-cellular-biomedicine-group-says-en/brief-cellular-biomedicine-group-says-enters-securities-purchase-agreement-with-certain-investors-idUSFWN1PQ16A", "country": "US", "domain_rank": 408, "title": "BRIEF-Cellular Biomedicine Group Says Enters Securities Purchase Agreement With Certain Investors", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-31T22:04:00.000+02:00", "replies_count": 0, "uuid": "0762aeaae4456f1dfd508de65dd6972e4ed0e1b0"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-cellular-biomedicine-group-says-en/brief-cellular-biomedicine-group-says-enters-securities-purchase-agreement-with-certain-investors-idUSFWN1PQ16A", "ord_in_thread": 0, "title": "BRIEF-Cellular Biomedicine Group Says Enters Securities Purchase Agreement With Certain Investors", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-cellular biomedicine group says enters securities", "sentiment": "negative"}, {"name": "reuters) - cellular biomedicine group inc", "sentiment": "neutral"}, {"name": "sec", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 31 (Reuters) - Cellular Biomedicine Group Inc:\n* CELLULAR BIOMEDICINE GROUP SAYS ON JAN 30, CO ENTERED INTO A SECURITIES PURCHASE AGREEMENT WITH CERTAIN INVESTORS - SEC FILING\n* CELLULAR BIOMEDICINE GROUP - PURSUANT TO PURCHASE AGREEMENT, CO AGREED TO SELL TO INVESTORS AGGREGATE OF 1.7 MILLION SHARES OF CO‘S STOCK AT $17.80/SHARE\n* CELLULAR BIOMEDICINE GROUP - ‍PURSUANT TO AGREEMENT, INVESTORS HAVE RIGHT TO NOMINATE 1 DIRECTOR TO BOARD TO STAND FOR ELECTION AT 2018 ANNUAL MEETING Source text: ( bit.ly/2rSN3z7 ) Further company coverage:\n ", "external_links": ["http://bit.ly/2rSN3z7", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-31T22:04:00.000+02:00", "crawled": "2018-02-01T15:24:52.000+02:00", "highlightTitle": ""}